• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Changes in opioid or nonopioid pain treatments not attributable to state opioid prescribing laws

byDavid XiangandHarsh Shah
March 30, 2022
in Chronic Disease, Orthopedic Surgery, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. No changes in opioid or nonopioid pain prescribing patterns were attributable to state laws.

2. State laws were associated with no significant change in the supply of opioid prescriptions.

Evidence Rating Level: 2 (Good)

Study Rundown: Over the past 2 decades, clinical guidelines for the management of acute and chronic noncancer pain have emphasized the use of nonopioid alternatives. States have also passed multiple types of laws designed to reduce opioid prescribing, including cap laws that limit the dose or duration of opioid prescriptions, pill mill laws that prevent rogue clinics from issuing opioids without medical indication, and mandatory prescription drug monitoring programs that require prescribers to check the program before prescribing an opioid. However, there is a gap in knowledge as to whether state opioid prescribing laws have influenced opioid prescribing patterns. This study found that there were no substantial changes in the pattern of opioid prescribing or nonopioid pain treatment attributable to state laws among commercially insured patients. This study was limited by factors such as not being generalizable to non-commercially insured populations and being imprecise for some estimates, as well as the inability to assess clinical appropriateness of pain treatments due to using claims data. Nevertheless, these study’s findings are significant, as they demonstrate that any changes in opioid prescription patterns are not attributable to state opioid prescribing laws among commercially insured US adults.

Click to read the study in AIM

Relevant Reading: Change in Per Capita Opioid Prescriptions Filled at Retail Pharmacies, 2008–2009 to 2017–2018

In-Depth [retrospective cohort study]: This study examined 7,694,514 commercially insured adults in the United States from 2008 to 2019, in 13 states that implemented a single law of interest in a 4-year period. Patients who were 18 years or older and continuously enrolled in insurance were eligible for the study. Patients who were diagnosed with cancer, excluding skin cancer, at any point during the study period were excluded from the study. The primary outcome measured was the proportion of patients receiving an opioid prescription or guideline-concordant nonopioid pain treatment per month. Outcomes in the primary analysis were assessed via an augmented synthetic control approach that weights the control states so that the magnitude of and time trends in outcomes and covariates during the prelaw period align as closely as possible in the treatment and control states. Based on the analysis, laws were associated with small-in-magnitude and non-statistically significant changes in outcomes. For adults overall and those with chronic noncancer pain, the state laws were associated with a change of less than 1% in the proportion of patients receiving an opioid prescription and a change of less than 2% in the proportion of patients receiving any guideline-concordant nonopioid treatment. The laws examined were also associated with a change of less than 1 in the days’ supply of opioid prescriptions. Overall, this study demonstrated that there are not any substantial changes in opioid prescription patterns or nonopioid pain treatment prescription patterns that could be attributable to state laws for commercially insured patients. This suggests that declining trends in opioid prescribing are probably driven by other factors such as changing clinical guidelines or professional norms.

RELATED REPORTS

Medical cannabis provides little improvement to sleep in chronic pain patients

Spectrophotometric assays for methadone may be effective for diversion control

Telemedicine bridge clinics may be helpful for opioid use disorder treatment

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: back painback pain therapyopioidopioid crisisopioid epidemicopioid prescribing lawspain
Previous Post

Sensorimotor religious and spiritual traditions may improve mental health outcomes

Next Post

Cessation of aspirin in older adults not associated with adverse health effects

RelatedReports

Parental cannabis use increasing, cigarette use decreasing
Chronic Disease

Medical cannabis provides little improvement to sleep in chronic pain patients

May 27, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Wellness

Spectrophotometric assays for methadone may be effective for diversion control

April 26, 2022
No obesity paradox found between BMI, stroke, and death
Chronic Disease

Telemedicine bridge clinics may be helpful for opioid use disorder treatment

April 25, 2022
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Wellness

Wellness Check: Addictions

April 21, 2022
Next Post
Aspirin therapy linked to fewer cases of preeclampsia

Cessation of aspirin in older adults not associated with adverse health effects

Publication of pneumonia antibiotic guidelines changed prescribing trends

Prenatal exposure to antipsychotic medications not associated with increased risk of neurodevelopmental disorders in offspring

Influenza vaccine not associated with increased risk of epilepsy in children

Single-dose Ad26.COV2.S reduces risk of COVID-related hospitalization and death in South African healthcare workers

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.